MSB 1.09% $1.39 mesoblast limited

$5.10 Bell Potter securities re-rates MSB, page-23

  1. 4,491 Posts.
    lightbulb Created with Sketch. 346

    Any ideas what this is about? Bell Potter's John Hester is using definitive wording, yet the latest announcement is using non-definitive wording throughout such as "proposed/intends/believes/expected/intent/FDA indicated" (SI is learning at least lol).

    https://hotcopper.com.au/data/attachments/5610/5610449-456cee5eadadeb6f3392768d836813ce.jpg

    In this instance the announcement used "proposed" re trial and "intends" re (BM CTN).

    Bell Potter and their current MSB analyst, John Hester, may again need to be taken with more than a grain of salt, more like a boulder.

    I'm not the sharpest tool in the shed so maybe I'm missing something, but it looks like misleading ramping to me, some here have speculated it's to talk up a CR, who knows?

    HC LINK
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.